Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why withhold a Press Release of good news?
13
Jan 08, 2013 12:50PM
12
opc
Jan 08, 2013 06:32PM
7
opc
Jan 09, 2013 12:21AM
14
Jan 09, 2013 01:41AM
5
Jan 09, 2013 03:25PM
9
Jan 09, 2013 04:00PM
4
Jan 09, 2013 04:26PM
1
opc
Jan 09, 2013 05:18PM
7
Jan 09, 2013 07:29PM

opc
Jan 09, 2013 07:46PM
7
Jan 10, 2013 03:53PM
2
Jan 10, 2013 04:02PM
9
Jan 10, 2013 04:07PM
2
Jan 10, 2013 04:14PM
3
Jan 10, 2013 04:14PM
2
opc
Jan 10, 2013 10:39PM

Jan 10, 2013 10:46PM
2
Jan 11, 2013 05:53AM
1
opc
Jan 11, 2013 06:59AM
7
Jan 11, 2013 10:46AM

opc
Jan 11, 2013 08:05PM

"And as to Leckrone, it seems most folks believe he is no longer in the driver's seat on the issuance of PRs for PTSC. I certainly hope so, but even if he is, I still can't see a logical reason for withholding a PR on the NDCA Markman ruling."

There is one scenario which I hope isn't 'behind the curtains waiting to ambush us."

That is the scenario where an individual or consortium seeks to hold down PTSC's stock price while the said individual or consortium builds cash reserves to take the company private at a bargain rate so that said individual or consortium alone is able to take advantage of MMP revenues after such a change in control.

Share
New Message
Please login to post a reply